154 related articles for article (PubMed ID: 11596960)
21. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.
Fults D; Pedone CA; Thompson GE; Uchiyama CM; Gumpper KL; Iliev D; Vinson VL; Tavtigian SV; Perry WL
Int J Oncol; 1998 Apr; 12(4):905-10. PubMed ID: 9499454
[TBL] [Abstract][Full Text] [Related]
22. LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas.
Fleischer M; Kessler R; Klammer A; Warnke JP; Eschrich K
Genes Chromosomes Cancer; 2011 Dec; 50(12):1010-20. PubMed ID: 21987444
[TBL] [Abstract][Full Text] [Related]
23. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of loss of heterozygosity around three candidate tumor suppressor genes on chromosome 10q in astrocytomas.
Terada K; Tamiya T; Daido S; Kambara H; Tanaka H; Ono Y; Matsumoto K; Ito S; Ouchida M; Ohmoto T; Shimizu K
J Neurooncol; 2002 Jun; 58(2):107-14. PubMed ID: 12164681
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
26. Chromosome 17 allelic loss in astrocytic tumors and its clinico-pathologic implications.
Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Ninomiya H; Hayakawa T
Clin Neuropathol; 1997; 16(4):220-6. PubMed ID: 9266149
[TBL] [Abstract][Full Text] [Related]
27. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
28. Genetic aberration on chromosome 10 in human oral squamous cell carcinoma.
Yamashita Y; Miyakawa A; Mochida Y; Aisaki K; Yama M; Shiiba M; Watanabe T; Yokoe H; Uzawa K; Imai Y; Tanzawa H
Int J Oncol; 2002 Mar; 20(3):595-8. PubMed ID: 11836574
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.
Fujisawa H; Reis RM; Nakamura M; Colella S; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 2000 Jan; 80(1):65-72. PubMed ID: 10653004
[TBL] [Abstract][Full Text] [Related]
30. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
[TBL] [Abstract][Full Text] [Related]
31. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
[TBL] [Abstract][Full Text] [Related]
32. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.
Hartmann C; Nümann A; Mueller W; Holtkamp N; Simon M; von Deimling A
Int J Cancer; 2004 Mar; 108(6):839-44. PubMed ID: 14712485
[TBL] [Abstract][Full Text] [Related]
33. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.
Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB
J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770
[TBL] [Abstract][Full Text] [Related]
34. LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation.
Pasini A; Iorio P; Bianchi E; Cerasoli S; Cremonini AM; Faedi M; Guarnieri C; Guiducci G; Riccioni L; Molinari C; Rengucci C; Calistri D; Giordano E
Oncol Rep; 2012 Dec; 28(6):2271-7. PubMed ID: 22992787
[TBL] [Abstract][Full Text] [Related]
35. Somatic mutations of PTEN in glioblastoma multiforme.
Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R
Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors.
Sarkar C; Chattopadhyay P; Ralte AM; Mahapatra AK; Sinha S
Cancer Genet Cytogenet; 2003 Jul; 144(2):156-64. PubMed ID: 12850379
[TBL] [Abstract][Full Text] [Related]
37. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK
Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of genomic abnormalities in human gliomas.
Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Cancer Genet Cytogenet; 1994 Apr; 73(2):122-9. PubMed ID: 8174086
[TBL] [Abstract][Full Text] [Related]
39. Association of chromosome 10 losses and negative prognosis in oligoastrocytomas.
Bissola L; Eoli M; Pollo B; Merciai BM; Silvani A; Salsano E; Maccagnano C; Bruzzone MG; Fuhrman Conti AM; Solero CL; Giombini S; Broggi G; Boiardi A; Finocchiaro G
Ann Neurol; 2002 Dec; 52(6):842-5. PubMed ID: 12447941
[TBL] [Abstract][Full Text] [Related]
40. Molecular and clinical analysis of glioblastoma with an oligodendroglial component (GBMO).
Nakamura H; Makino K; Kuratsu J
Brain Tumor Pathol; 2011 Jul; 28(3):185-90. PubMed ID: 21629979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]